950220.KQ
Price:
$1939
Market Cap:
$13.00B
As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Industry
Biotechnology
IPO Date
2021-03-16
Stock Exchange
KOE
Ticker
950220.KQ
According to NeoImmuneTech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -10955279696.00. This represents a change of -127.55% compared to the average of 39.77B of the last 4 quarters.
The mean historical Enterprise Value of NeoImmuneTech, Inc. over the last ten years is 16.39T. The current -10955279696.00 Enterprise Value has changed -106.68% with respect to the historical average. Over the past ten years (40 quarters), 950220.KQ's Enterprise Value was at its highest in in the March 2020 quarter at 41.07T. The Enterprise Value was at its lowest in in the September 2025 quarter at -30572820250.00.
Average
16.39T
Median
12.70T
Minimum
-30675223000.00
Maximum
35.28T
Discovering the peaks and valleys of NeoImmuneTech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0.09%
Maximum Annual Enterprise Value = 35.28T
Minimum Annual Increase = -5750.59%
Minimum Annual Enterprise Value = -30675223000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 68.62B | -5750.59% |
| 2024 | -1214325875.00 | -94.75% |
| 2023 | -23126960000.00 | -24.61% |
| 2022 | -30675223000.00 | -100.12% |
| 2021 | 25.33T | -28.16% |
| 2020 | 35.26T | 0.09% |
| 2019 | 35.23T | -0.15% |
The current Enterprise Value of NeoImmuneTech, Inc. (950220.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.76B
5-year avg
5.07T
10-year avg
16.39T
NeoImmuneTech, Inc.’s Enterprise Value is
| Company | Enterprise Value | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoImmuneTech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeoImmuneTech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NeoImmuneTech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NeoImmuneTech, Inc. (950220.KQ)?
What is the 3-year average Enterprise Value for NeoImmuneTech, Inc. (950220.KQ)?
What is the 5-year average Enterprise Value for NeoImmuneTech, Inc. (950220.KQ)?
How does the current Enterprise Value for NeoImmuneTech, Inc. (950220.KQ) compare to its historical average?